These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 21124337)
1. Evidence for epistatic interactions in antiepileptic drug resistance. Kim MK; Moore JH; Kim JK; Cho KH; Cho YW; Kim YS; Lee MC; Kim YO; Shin MH J Hum Genet; 2011 Jan; 56(1):71-6. PubMed ID: 21124337 [TBL] [Abstract][Full Text] [Related]
2. Association of a synonymous GAT3 polymorphism with antiepileptic drug pharmacoresistance. Kim DU; Kim MK; Cho YW; Kim YS; Kim WJ; Lee MG; Kim SE; Nam TS; Cho KH; Kim YO; Lee MC J Hum Genet; 2011 Sep; 56(9):640-6. PubMed ID: 21776001 [TBL] [Abstract][Full Text] [Related]
3. GABRG2, rs211037 is associated with epilepsy susceptibility, but not with antiepileptic drug resistance and febrile seizures. Balan S; Sathyan S; Radha SK; Joseph V; Radhakrishnan K; Banerjee M Pharmacogenet Genomics; 2013 Nov; 23(11):605-10. PubMed ID: 24061200 [TBL] [Abstract][Full Text] [Related]
4. Gene-to-gene interaction between sodium channel-related genes in determining the risk of antiepileptic drug resistance. Jang SY; Kim MK; Lee KR; Park MS; Kim BC; Cho KH; Lee MC; Kim YS J Korean Med Sci; 2009 Feb; 24(1):62-8. PubMed ID: 19270815 [TBL] [Abstract][Full Text] [Related]
5. Major vault protein (MVP) gene polymorphisms and drug resistance in mesial temporal lobe epilepsy with hippocampal sclerosis. Balan S; Radhab SK; Sathyan S; Vijai J; Banerjee M; Radhakrishnan K Gene; 2013 Sep; 526(2):449-53. PubMed ID: 23751308 [TBL] [Abstract][Full Text] [Related]
6. Ability of epistatic interactions of cytokine single-nucleotide polymorphisms to predict susceptibility to disease subsets in systemic sclerosis patients. Beretta L; Cappiello F; Moore JH; Barili M; Greene CS; Scorza R Arthritis Rheum; 2008 Jul; 59(7):974-83. PubMed ID: 18576303 [TBL] [Abstract][Full Text] [Related]
7. Polymorphism of the MDR1/ABCB1 C3435T drug-transporter and resistance to anticonvulsant drugs: a meta-analysis. Bournissen FG; Moretti ME; Juurlink DN; Koren G; Walker M; Finkelstein Y Epilepsia; 2009 Apr; 50(4):898-903. PubMed ID: 19178561 [TBL] [Abstract][Full Text] [Related]
8. Association analysis of intractable epilepsy with C3435T and G2677T/A ABCB1 gene polymorphisms in Iranian patients. Sayyah M; Kamgarpour F; Maleki M; Karimipoor M; Gharagozli K; Shamshiri AR Epileptic Disord; 2011 Jun; 13(2):155-65. PubMed ID: 21636342 [TBL] [Abstract][Full Text] [Related]
9. No association of ABCB1 polymorphisms with drug-refractory epilepsy in a north Indian population. Lakhan R; Misra UK; Kalita J; Pradhan S; Gogtay NJ; Singh MK; Mittal B Epilepsy Behav; 2009 Jan; 14(1):78-82. PubMed ID: 18812236 [TBL] [Abstract][Full Text] [Related]
10. Significance of MDR1 gene polymorphism C3435T in predicting drug response in epilepsy. Shaheen U; Prasad DK; Sharma V; Suryaprabha T; Ahuja YR; Jyothy A; Munshi A Epilepsy Res; 2014 Feb; 108(2):251-6. PubMed ID: 24300029 [TBL] [Abstract][Full Text] [Related]
11. The controversial association of ABCB1 polymorphisms in refractory epilepsy: an analysis of multiple SNPs in an Irish population. Shahwan A; Murphy K; Doherty C; Cavalleri GL; Muckian C; Dicker P; McCarthy M; Kinirons P; Goldstein D; Delanty N Epilepsy Res; 2007 Feb; 73(2):192-8. PubMed ID: 17125969 [TBL] [Abstract][Full Text] [Related]
12. Non-response to antiepileptic pharmacotherapy is associated with the ABCC2 -24C>T polymorphism in young and adult patients with epilepsy. Ufer M; Mosyagin I; Muhle H; Jacobsen T; Haenisch S; Häsler R; Faltraco F; Remmler C; von Spiczak S; Kroemer HK; Runge U; Boor R; Stephani U; Cascorbi I Pharmacogenet Genomics; 2009 May; 19(5):353-62. PubMed ID: 19415824 [TBL] [Abstract][Full Text] [Related]
13. Therapeutic drug monitoring and clinical outcomes in epileptic Egyptian patients: a gene polymorphism perspective study. Ebid AH; Ahmed MM; Mohammed SA Ther Drug Monit; 2007 Jun; 29(3):305-12. PubMed ID: 17529887 [TBL] [Abstract][Full Text] [Related]
14. Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy. Canevini MP; De Sarro G; Galimberti CA; Gatti G; Licchetta L; Malerba A; Muscas G; La Neve A; Striano P; Perucca E; Epilepsia; 2010 May; 51(5):797-804. PubMed ID: 20545754 [TBL] [Abstract][Full Text] [Related]
15. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease. Török HP; Glas J; Endres I; Tonenchi L; Teshome MY; Wetzke M; Klein W; Lohse P; Ochsenkühn T; Folwaczny M; Göke B; Folwaczny C; Müller-Myhsok B; Brand S Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129 [TBL] [Abstract][Full Text] [Related]
16. Antiepileptic drug resistance and tolerance in epilepsy. Widdess-Walsh P; Devinsky O Rev Neurol Dis; 2007; 4(4):194-202. PubMed ID: 18195671 [TBL] [Abstract][Full Text] [Related]
17. Drug resistance in epilepsy: why is a simple explanation not enough? Löscher W; Sills GJ Epilepsia; 2007 Dec; 48(12):2370-2. PubMed ID: 18088269 [No Abstract] [Full Text] [Related]
18. Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1. Siddiqui A; Kerb R; Weale ME; Brinkmann U; Smith A; Goldstein DB; Wood NW; Sisodiya SM N Engl J Med; 2003 Apr; 348(15):1442-8. PubMed ID: 12686700 [TBL] [Abstract][Full Text] [Related]
19. Changes in medication associated with epilepsy-related hospitalisation: a case-crossover study. Handoko KB; Zwart-van Rijkom JE; Hermens WA; Souverein PC; Egberts TC Pharmacoepidemiol Drug Saf; 2007 Feb; 16(2):189-96. PubMed ID: 17036373 [TBL] [Abstract][Full Text] [Related]
20. Association and gene-gene interactions of eight common single-nucleotide polymorphisms with pediatric asthma in middle china. Wu X; Li Y; Chen Q; Chen F; Cai P; Wang L; Hu L J Asthma; 2010 Apr; 47(3):238-44. PubMed ID: 20394509 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]